Loans
Loans
HomeNewsTrendsHealthVoluntary use of masks must be promoted in view of new XE variant: Experts

Voluntary use of masks must be promoted in view of new XE variant: Experts

The World Health Organisation (WHO) has issued a warning against XE, a new variant of Omicron first detected in the UK, and suggested that it could be more transmissible than any COVID-19 strain so far.

April 12, 2022 / 15:02 IST
Representative image.

Voluntary use of masks must be promoted in the country in view of COVID-19’s new XE variant, healthcare experts said, calling it the single-most effective intervention against all variants of the coronavirus.

After more than two years, mandatory wearing of masks was lifted in Maharashtra and Delhi.

Wearing masks was mandatory in public in view of the COVID-19 infection and not following this protocol drew a fine as high as Rs 2,000.

The World Health Organisation (WHO) has issued a warning against XE, a new variant of Omicron first detected in the UK, and suggested that it could be more transmissible than any COVID-19 strain so far.

The XE variant is a combination or recombinant of both sub-variants — BA.1 and BA.2 — of Omicron.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Asked about the new variant’s impact on India, which is witnessing a dip in cases ever since the Omicron driven wave started receding in February, the experts said that there is no need to panic but advocated for voluntary use of masks in public.

Gujarat reported its first case of the XE variant on Saturday after authorities got the genome sequencing results of the sample taken from a man from Mumbai, who had tested positive for COVID-19 during his visit to Vadodara on March 12, a state official said.

Earlier to this, Mumbai civic body officials had said that a woman who had arrived from South Africa in February-end and tested positive in March has been infected by the XE variant, but the health ministry has not confirmed it to be so.

Eminent virologist T Jacob John said XE means there were XA, XB, XC and XD earlier but none of them were given much attention.

"XE gained attention since it became common in the UK. It had about 10 per cent higher transmissibility than the BA.2 lineage of Omicron. Many media persons misread this as 10 times more transmissible than BA.2 and thus, XE gained false notoriety,” he told PTI.

"After the Omicron wave (predominantly BA.2) receded by the third week of February, there was no cause for alarm even if this one virus is confirmed as XE. No change in our tactics is called for. While masks have many benefits other than Covid control, and should be generally promoted by health education, mandate with punishment for non-compliance is quite unnecessary,” he added.

Giridhara R Babu, professor and the head of lifecourse epidemiology at the Public Health Foundation of India, said reporting of the XE variant should be seen as a strength of the surveillance system.

"XE is a recombinant sublineage of one of the many Omicron BA.1 and BA.2 variants. It is not a variant of concern. We should not get worked up due to its reporting. Certainly, we should refrain from implementing any reactive panic measures. We should recollect that the Delta variant had several sublineages before Omicron finally replaced it,” he told PTI.

Babu said the precautions followed for Omicron should continue before more data on its transmissibility in India emerges.

"I feel that voluntary use of masks should be encouraged as this is the single most effective intervention against all variants. However, there should not be any penalty, and instead of a mandate, ensuring availability and free distribution of masks, especially in closed space settings, will be helpful,” he added.

Babu said there is no data to support warranting restrictions in movement. Field investigations of clusters and genomic sequencing should be sustained and strengthened to monitor how newer sublineages might impact, he said.

Dr Chandrakant Lahariya, a physician and leading epidemiologist who has been involved in India’s pandemic response, said the hype around the XE variant is "uncalled for and exaggerated”.

"It has no relevance and there is no reason to be concerned. The only relevant thing of reporting of XE shows that India’s genomic surveillance system is working. In this backdrop, XE being detected and reported from India is a positive public health sign but doesn’t change anything for the public or for the COVID-19 response policy,” he said.

PTI
first published: Apr 12, 2022 03:02 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347